Thanks, Mike. Good afternoon, everyone and thanks for joining us. I'll begin with the business update. Mike will review the financials and guidance and then we'll open it up for your questions. Mercury's bookings increased 34% year-over-year in the first quarter, following 27% growth in Q4 of fiscal '22. Actual results in the quarter exceeded the high end of our guidance across all metrics and we're raising the low end of our full year outlook as a result. The largest bookings in the first quarter were LTAMDS, the SDA tranche tracking layer and AMCS. We also received the F-18 and [indiscernible] Block 2 orders that moved from Q4. Driven by strong Q1 bookings, our book-to-bill was 1.17 in Q1 and 1.14 over the last 12 months. Backlog grew 22% year-over-year. This backlog, combined with strong bookings expected in Q2 and for the remainder of the year, position us well to deliver increased revenue and EBITDA in Q2 and the second half of fiscal '23. Our results for the first quarter reflected the second half weighting of orders in fiscal '22. Together with continued order delays, long semiconductor lead times and other supply constraints. Q1 is also typically our seasonally weakest quarter. Total revenue increased 1% year-over-year Organic revenue was down 4%, a far better result than Q1 last year. We expect organic growth to turn positive in the second quarter. Our largest revenue programs were F-35, LTAMDs, Aegis, F-18 and SEWIP. Q1 adjusted EBITDA was down 19% year-over-year as expected. This was driven primarily by the second half weighting of orders in fiscal '22 and program mix. We expect margins to increase in Q2 and as the year progresses. Free cash was an outflow of $73 million which we believe will be the low watermark for the year. This primarily reflected order delays and supply chain disruptions that affected the timing of collections in the quarter as well as purchase of raw materials to support future revenues. In addition, we saw customers unusually holding payments at the end of the quarter. We expect free cash flow to improve substantially in Q2 and grow through the second half of fiscal '23, resulting in positive free cash flow for the year. We continue to see high levels of new business activity. Design wins in Q1 totaled more than $135 million in estimated time volume. Turning to Slide 4. Q1 marked the beginning of Mercury's fourth fiscal year dealing with the effects of the pandemic. In the near term, our business in the industry will continue to face challenging macro forces. However, it's clear that the issues impacting us today are not demand related. They're supply and timing related, they're short term and they're not unique to Mercury. We're executing our plan to control what we can and we're optimistic about the future given our positioning. After several years of COVID-related challenges, we believe that we've entered a multiyear period of accelerating growth and profitability similar to the period post sequestration in 2013. Reflecting back to the beginning of the pandemic, Mercury's fiscal '20 was in the health care crisis phase. We navigated this period well with minimal impacts on our employees, operations and financials. Bookings, revenue and adjusted EBITDA were up more than 20% over the year. In fiscal '21, we saw a COVID-related slowdown in orders. Bookings didn't grow as much in the second half as we anticipated, declining nearly 8% for the year. Our book-to-bill fell to 0.95 from the prior year's 1.2, the lowest in more than a decade. Revenue still grew 16% year-over-year. Adjusted EBITDA was up more than 14%. In fiscal '22, we saw the full effects of COVID beginning early in the year. The Delta variant reduced our manufacturing productivity and the defense budget was delayed 165 days. We experienced significant semiconductor supply chain disruptions and higher attrition as well as a nation, all magnified by the prior year's order slowdown in the second half. As a result, total revenue grew 7% in fiscal '22, less than we had anticipated. Organic revenue declined 5% and we ended the year with adjusted EBITDA margins roughly flat. Supply chain disruptions had an outsized impact on H1, H2 linearity. Working capital investments increased as the year progressed, with free cash flow turning negative as a result. However, bookings rebounded strongly in FY '22, growing 21% year-over-year, leading to a 1.08 book-to-bill and crossing $1 billion for the first time. Most of this rebound occurred in the second half with bookings growing 33% versus H2 of the prior year. This order timing, coupled with dramatically longer semiconductor lead times is resulting in our fiscal '23 financial performance also being more back-end loaded than we experienced pre-pandemic. Unlike last year, however, bookings in fiscal '23 are off to a great start. We expect faster growth in the second quarter and the first half to be much improved versus H1 of fiscal '22. This sets the stage with strong full year bookings and a positive book to bill. We believe that Q1 marked the bottom in fiscal '23 for organic revenue growth, free cash flow and margins. Given the strong order flow, we anticipate a return to organic growth in the second quarter and for fiscal '23 as a whole. We expect to deliver stronger earnings and positive free cash flow as well as improved working capital efficiency over time as the supply chain headwind subside. As I said earlier, what Mercury has experienced since the start of the pandemic is much the same as sequestration nearly a decade ago in terms of the multiyear impact on our financial results. The enhancements that we made in the business at that time led to accelerated growth and value creation over the next 5 years. For fiscal years '13 through '18, Mercury ranked second and first among our Tier 2 defense peers for compound annual growth in revenue and adjusted EBITDA, respectively. Similarly, through impact with strengthening our business fundamentals once again. Looking forward to fiscal '24, we believe that lead times for high-end semiconductors will begin to improve in the second half. We've already begun to see a shortening of semiconductor lead times on the low end. We expect stronger bookings and organic growth, continued margin expansion and greatly improved free cash flow as we release working capital, all of which should position us for further growth and value creation as we move forward. Turning to Slide 5. We believe today's geopolitical environment is the most challenging since the cold war. The risks related to China and Taiwan are potentially more significant than what we're experiencing today with Russia and Ukraine and the time line is moving to the left. The semiconductor industry and the defense industrial base in Europe and the U.S. are not what they need to be to build the military stockpiles and the new capabilities required in this threat environment. We appear to be heading into a super cycle in U.S. and allied defense spending. The change, however, for both the government and the defense industry is clearly on the supply side, whether it be the availability of semiconductors and other materials, labor or now inflation. In the near term, the industry is dealing with an ongoing shortfall in government contracting personnel. We're also beginning the new fiscal year under a defense budget continuing resolution. This means the contracting environment will likely remain challenging in the short term. We're not expecting a defense appropriation bill until after the midterm elections. On a positive note, once that bill is passed, the GFY '23 budget is currently expected to increase year-over-year. That said, given inflation, the real defense spending and buying power increases could be far less. So overall, the demand environment is strong and appears to be getting stronger. Although the industry is dealing with headwinds, we believe that they're temporary. We expect to see a shift to tailwinds as defense spending grows and supply chain conditions improve. Turning to Slide 6. At the Mercury level, the supply chain environment remains challenging but stable. Although we're still seeing supply delays in isolated quality issues, we're experiencing fewer supply decommits compared with Q4. Lead times overall have not increased but is [indiscernible] extremely long for high-end semiconductors. Mercury's sophisticated end-to-end processing platform powers some of the most critical A&D missions. High-end processing represents about 70% of our business and it's where Mercury likely has the largest opportunity to grow over the next 5 years. It's also where the global supply chain has been most disrupted. High-end semiconductors are at the heart of many of our offensive and defensive weapon systems and have rapidly become the long lead time for defense development and production. Prior to the pandemic, semiconductor processor lead times were 10 to 12 weeks. They increased rapidly in the second half of fiscal '21 and now range from 52 to 99 weeks. Putting this in perspective, this means that high-end semiconductor material orders that we're placing today, support revenues in our third and fourth quarters of fiscal '24. It's not until this point that we believe that lead times and availability will begin to improve. Throughout this multiyear period, we've used the strength of our balance sheet to invest in working capital to mitigate supply chain risk as best we can, positioning Mercury to deliver stronger and more consistent results over time. When the supply chain conditions normalize, we expect a significant release of cash related to inventory and unbilled receivables from our balance sheet. We also continue to deal with semiconductor-related inflationary pressures. Semiconductors equate to 38% of our direct supply spend far more than our peers', we believe. We've taken aggressive steps to maintain the strongest possible margins in this environment and they're working. These include repricing standard products and incorporating price adjustment mechanisms in our rates-based businesses and multiyear proposals. We've also shortened the validity of our quotes to capture any near-term inflationary effects. Given the short-cycle nature of our model, it's likely that the impacts of supply chain inflation will begin to diminish over time as these actions result in more of the business being priced at market rates. We're making good progress in managing the industry headwinds through our 1MPACT program. Much like our approach to sequestration, we're laying the foundation for Mercury to achieve its full growth and profit potential over the next 5 years. We've seen tremendous changes since we launched 1MPACT at the beginning of fiscal '22. We began by simplifying and streamlining our organizational structure and strengthening the leadership team and we continue to do so. Mitch Stevison, our former Chief Growth Officer, who joined us from Raytheon 12 months ago, recently took the helm as President of our Processing division which accounts for approximately 70% of total company revenue. Mitch knows Mercury well and has hit the ground running in his new role. We also have focused 1MPACT on margin expansion initiatives in fiscal '22 and we're now pushing their execution deeper into the business. Effective October 3, Alan [ph] joined us to accelerate these efforts as our Senior VP of Execution excellence. Alan was previously at Raytheon in their missiles and defense division. He'll be responsible for supply chain, operations, engineering and program management reporting to me. We're pleased to welcome Alan to the team. As the environment became more challenging in fiscal '22, we pivoted 1MPACT towards those areas that could help mitigate risk and deliver the most immediate financial benefits. This year, in addition to pricing, we continue to focus on supply chain risk mitigation, working capital burn down and accelerated cash release. Another initiative is R&D investment efficiency and returns, building on the progress last year. Our digital transformation initiatives and engineering and operations will help improve our cost structure and performance over the long term as well. We're also making good progress in our facility footprint strategy. In Q1, we consolidated 2 engineering teams and a new center of excellence in Fremont, California. We're on track to consolidate our Mesa, Arizona facility into the Phoenix site in the second quarter and we expect to release 2 additional buildings in California by the end of fiscal '23. As it relates to M&A, 1MPACT is about leveraging our proven ability to integrate and grow acquired businesses but at a greater scale going forward. The environment continues to be active and will remain focused on our existing M&A themes. With that, I’d like to turn the call over to Mike. Mike?